Immune Monitoring During ASP2215 Therapy in Relapsed/Ref

  • He, Fiona C (PI)
  • Ustun, Celalettin, (Prior Principal Investigator)

Project: Research project

Description

Immune Monitoring During ASP2215 Therapy in Relapsed/Refractory Acute Myeloid Leukemia (AML)
StatusActive
Effective start/end date5/1/163/31/20

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Immunologic Monitoring
Acute Myeloid Leukemia
Therapeutics
ASP2215